Article
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
8 Sept 2022
Abstract excerpt
NF-κB transcription factors are major drivers of tumor initiation and progression. NF-κB signaling is constitutively activated by genetic alterations or environmental signals in many human cancers, where it contributes to almost all hallmarks of malignancy, including sustained proliferation, cell death resistance, tumor-promoting inflammation, metabolic reprogramming, tissue invasion, angiogenesis, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
